Press - IVI

29 October 2025

New Advances in Reproductive Bioengineering: Ovarian and Endometrial Organoids Open New Paths for Egg Preservation and Uterine Tissue Regeneration

These organoids are three-dimensional structures grown in the lab from cells that mimic the shape and function of the target organ or tissue One of the most promising applications of ovarian organoids is the preservation and restoration of fertility in women whose ovaries have been damaged due to cancer treatments In the case of human… View Article

2 July 2025

Umbilical Cord–Derived Platelet-Rich Plasma: A New Approach to Reducing Infertility and Implantation Failure in Women with Endometrial Pathologies

This pioneering study documents, for the first time, the use of allogeneic (donor-derived) platelet-rich plasma (PRP) obtained from umbilical cord blood as a treatment to regenerate atrophic or thin endometrium, as well as in cases of Asherman’s syndrome Allogeneic PRP contains a significantly higher concentration of growth factors and anti-inflammatory properties than autologous PRP, thanks… View Article

1 July 2025

Breakthrough in Male Fertility: Hyperspectral Imaging Enables Selection of Sperm with Higher Reproductive Potential

For the first time, using only light and a hyperspectral camera, this non-invasive technology captures the molecular fingerprint of individual sperm cells and generates a biochemical profile, allowing prediction of their ability to produce a viable embryo The technique does not damage or compromise sperm viability, making it a highly promising tool that could potentially… View Article

30 June 2025

A New Frontier in Female Infertility: Restoring Ovarian Function Through Stem Cell–Derived Proteins

A newly presented study by IVI at the 41st Annual Meeting of the European Society of Human Reproduction and Embryology (ESHRE) has demonstrated improved ovarian function in mice following the injection of a specific combination of key proteins The study, conducted in female mice with premature ovarian insufficiency (POI), resulted in a fivefold increase in… View Article

26 April 2025

Generating Sperm and Eggs from Stem Cells, Latest Advances in Artificial Intelligence, and the Next Revolution in Genetic Assessment

Barcelona hosts the congress of the world’s largest corporation exclusively dedicated to assisted human reproduction, bringing together over 1,300 professionals, researchers, and academics from 58 countries Denny Sakkas, Chief Scientific Officer IVIRMA North America and Associate Professor at Yale University School of Medicine, will discuss pioneering research on stem cell biology and tissue engineering aimed… View Article

25 April 2025

Use of Artificial Intelligence Reduces the Time to Achieve Pregnancy Through Assisted Reproduction by 7%

Additionally, AI-driven embryo selection increases pregnancy rates by 5%, reaching a cumulative increase of 7% Regarding gamete selection, AI potentially identifies sperm with the highest fertilization potential and embryos more likely to result in successful pregnancy. It also selects higher-quality eggs, particularly valuable for fertility preservation programs AI advancements presented at the congress offer substantial… View Article

24 April 2025

Whole-genome Sequencing in Preimplantation Genetic Diagnosis: unlocking the missing piece in the puzzle of embryo implantation

Current preimplantation genetic testing (PGT) detects macroscopic chromosomal anomalies and certain known hereditary disorders within specific family genetic histories. However, around 50% of euploid embryos fail to implant, with an additional 10% resulting in miscarriage The integration of clinical whole-genome sequencing (WGS) into PGT represents a promising strategy to overcome the limitations of current methodologies,… View Article

4 September 2024

I have contracted HPV. Will this affect my fertility?

Human papillomavirus (HPV) affects both women and men, with different implications for their fertility, especially when co-infected with chlamydia In women, HPV can cause lesions such as scarring, adhesions, or blockages in the fallopian tubes, while in men, it can impact sperm quality, motility, or even lead to DNA fragmentation There is also an increased… View Article

10 July 2024

Chemotherapy in testicular cancer patients can cause DNA changes in sperm

Four years after cancer treatment, most patients recover sperm concentration and motility, but little was known about how the treatment affects the epigenetics of human sperm, the mechanism that modifies genes and has the ability to activate or silence their expression This study, the largest conducted to date, suggests changes occurred in the sperm methylome… View Article

PRESS ROOM CONTACTS

Ricardo Pedrós
Lucía Renau

Email: prensa@ivi.es
Phone number: (0034) 96 317 36 10
Calle Colón, 1 - 46004 (Valencia)

Press room